---
title: "Meril GmbH v Respondent 1 and SWAT Medical AB (UPC CoA 635/2024, 05-05-2025)"
description: "The Court of Appeal set aside a Paris Central Division order that had given a European patent attorney and his company access to all pleadings and evidence in…"
url: https://pitch.law/academy/upc-court-of-appeal/upc-coa-635-2024-2025-05-05
lang: en
author: "UPC Case Law by Pitch"
editor: "Bart Lieben"
datePublished: 2026-11-18T10:07:21.211Z
dateModified: 2026-11-18T10:07:21.211Z
---

# Meril GmbH v Respondent 1 and SWAT Medical AB

Decision of the UPC Court of Appeal of 5 May 2025, UPC CoA 635/2024.

UPC Case Law by Pitch, edited by [Bart Lieben](https://pitch.law/team/bart-lieben) · Published 18-11-2026

## TL;DR

The Court of Appeal set aside a Paris Central Division order that had given a European patent attorney and his company access to all pleadings and evidence in a revocation counterclaim. Neither applicant had a validly appointed representative, so access could not be granted. The court also held that costs are normally not awarded in R 262.1(b) RoP access-to-file applications, and that a reasoned decision under R 235.3 RoP is effectively a default decision, so it can be challenged by an application to set aside under R 356.1 RoP.

## Key holding

Access to written pleadings and evidence under R 262.1(b) RoP must not be granted to members of the public who are not represented. A respondent who must be represented but files a Statement of response signed by himself has failed to lodge a Statement of response.

R 235.3 RoP is a lex specialis (a specific rule that prevails over the general one) for a late Statement of response on appeal. It needs no request, and the resulting reasoned decision is effectively a default decision, so R 356.1 RoP (application to set aside within one month of service) applies mutatis mutandis. Costs are not awarded in R 262.1(b) RoP applications, save for unnecessary costs under Art 69(3) UPCA in exceptional cases.

## Questions decided

1. Has a Statement of response been lodged if it is signed by a party not allowed to represent himself?
2. Can a party barred from self-representation file an R 293 RoP change of representative?
3. Does a reasoned decision under R 235.3 RoP require a request, and can it be set aside under R 356.1 RoP?
4. Can access under R 262.1(b) RoP be granted to unrepresented members of the public?
5. Are costs recoverable in applications for access to pleadings and evidence under R 262.1(b) RoP?

## Case details

- Court: Court of Appeal of the Unified Patent Court, Panel 2
- Panel: Rian Kalden (presiding judge, legally qualified judge); Ingeborg Simonsson (legally qualified judge, judge-rapporteur); Patricia Rombach (legally qualified judge)
- Date: 05-05-2025
- Case number(s): UPC CoA 635/2024, UPC CFI 15/2023
- Parties: Appellant: Meril GmbH (respondent and counterclaimant in the main proceedings at first instance); Respondents: Respondent 1 (name not stated in the published text) and SWAT Medical AB (applicants for access at first instance)
- Language of the proceedings: English
- Outcome: The Paris Central Division order of 14 October 2024 (ORD_37077/2024) was set aside, and the access application App_33487/2024 was dismissed.
- Official text on the court’s website (PDF): https://www.unified-patent-court.org/sites/default/files/files/api_order/15942A4475B0044559DB040767D898AE_en.pdf

## How to cite

Court of Appeal, Meril GmbH v Respondent 1 and SWAT Medical AB, UPC CoA 635/2024, Decision of 5 May 2025 (OSCOLA)

## Full summary

Read the full analyses for free — create a free account: https://pitch.law/academy/upc-court-of-appeal/upc-coa-635-2024-2025-05-05

Topics: [Confidentiality and access to the file](https://pitch.law/academy/upc-court-of-appeal/topics/confidentiality-and-access), [Procedure](https://pitch.law/academy/upc-court-of-appeal/topics/procedure)

## In the same case

- [Meril Italy Srl and others v Edwards Lifesciences Corporation, UPC CoA 464/2024, 25-11-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-464-2024-2025-11-25): The Court of Appeal upheld EP 3 646 825 as amended by Auxiliary Request II and confirmed that Meril's Myval Octacor heart valve system infringes it.
- [Meril GmbH and others v Edwards Lifesciences Corporation, UPC CoA 166/2025, 18-04-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-166-2025-2025-04-18): The Court of Appeal refused Meril's request to suspend the Munich Local Division's infringement decision in favour of Edwards Lifesciences pending Meril's appeal.
- [Meril GmbH v SWAT Medical AB and another, UPC CoA 635/2024, 12-02-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-635-2024-2025-02-12): A lawyer or European Patent Attorney who is personally a party before the UPC must still be represented by someone else.
- [Meril Life Sciences Pvt. Ltd v Respondent 1 and SWAT Medical AB, UPC CoA 636/2024, 12-02-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-636-2024-2025-02-12): A lawyer or European Patent Attorney who is a party before the UPC cannot represent himself and must instruct a separate authorised representative.

## More on confidentiality and access to the file

- [PAUSTIAN & PARTNER Patentanwälte mbB v NUC Electronics Europe GmbH and others, UPC CoA 163/2026, 11-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-163-2026-2026-11-11): The Court of Appeal granted a patent law firm access to the statements of appeal and statements of grounds of appeal in three closed appeals concerning EP 2 028 981.
- [The Walt Disney Company and others v InterDigital VC Holdings, Inc., UPC CoA 133/2026, 05-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-133-2026-2026-11-05): A request under R 262A RoP to stop the other party from accessing or using confidential information cannot be made for the first time on appeal for material already filed at first instance.
- [Netflix Services Germany GmbH and others v DivX, LLC, UPC CoA 176/2026, 02-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-176-2026-2026-11-02): The Court of Appeal refused Netflix's request for suspensive effect against the Munich Local Division's infringement decision in favour of DivX, even though the EPO Opposition Division revoked the patent after that decision.
